Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
The Pineal Gland01:02

The Pineal Gland

2.6K
The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
2.6K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

250
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
250
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

830
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
830
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

137
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
137
Understanding Sleep01:11

Understanding Sleep

636
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
636

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Leaky Gut to a Vulnerable Brain: Obesity-Associated Gut Barrier Failure in Colorectal Cancer and Cognitive Dysfunction.

Nutrients·2026
Same author

Adiponectin Inhibits Oxidative Stress and Tight Junction Protein Loss: Evidence from a Hepatic Encephalopathy Mouse Model and Brain Endothelial Cells.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Biosacetalin (1,1-Diethoxyethane) Improves Healthy Lifespan in <i>C. elegans</i> and Rats.

Antioxidants (Basel, Switzerland)·2026
Same author

Regulatory Functions of Long Non-coding RNAs and Circular RNAs in the Molecular Pathogenesis of Autism Spectrum Disorder.

Cellular and molecular neurobiology·2025
Same author

The Change of Noncoding RNA Expression in Olfactory Bulb of Hepatic Encephalopathy Mouse Model: Transcriptomic Analysis and Cellular Analysis.

CNS neuroscience & therapeutics·2025
Same author

Antitumor Effects of Metformin in Squamous Cell Carcinoma under Leptin Treatment Conditions.

Preventive nutrition and food science·2025

Related Experiment Video

Updated: Sep 21, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.6K

Hepatic Encephalopathy and Melatonin.

Archana Arjunan1, Dhiraj Kumar Sah2, Young Do Jung2

  • 1Department of Anatomy, Chonnam National University Medical School, Hwasun 58128, Korea.

Antioxidants (Basel, Switzerland)
|May 28, 2022
PubMed
Summary

Hepatic encephalopathy (HE) causes brain dysfunction due to ammonia buildup. This study explores how melatonin, a neurohormone, may reverse these effects, offering a potential new therapy for HE.

Keywords:
cognitive impairmenthepatic encephalopathyhyperammonemiamelatoninneuroinflammationneurotransmitter

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.2K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.0K

Related Experiment Videos

Last Updated: Sep 21, 2025

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
05:59

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

Published on: October 20, 2023

2.6K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.2K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.0K

Area of Science:

  • Neuroscience
  • Hepatology
  • Pharmacology

Background:

  • Hepatic encephalopathy (HE) is a severe complication of liver disease, leading to cognitive impairment and potentially death.
  • Current HE treatments are limited, necessitating novel therapeutic strategies.
  • Ammonia accumulation crossing the blood-brain barrier (BBB) is implicated in HE's neuropathology, causing oxidative stress and inflammation.

Purpose of the Study:

  • To investigate the mechanisms by which HE impairs brain function.
  • To elucidate the molecular actions of melatonin in reversing HE-induced central nervous system damage.
  • To explore melatonin as a potential therapeutic agent for hepatic encephalopathy.

Main Methods:

  • Review of scientific literature on HE pathogenesis and ammonia transport.
  • Analysis of studies on melatonin synthesis, secretion, and neuroprotective effects.
  • Examination of clinical data linking HE, liver cirrhosis, and melatonin levels.

Main Results:

  • HE is associated with impaired melatonin synthesis and circadian patterns.
  • Melatonin, a potent antioxidant, can cross the BBB and exert neuroprotective effects.
  • Ammonia accumulation triggers oxidative stress and inflammation, disrupting neuronal function.

Conclusions:

  • Melatonin holds promise as a therapeutic agent for hepatic encephalopathy.
  • Understanding melatonin's molecular mechanisms could lead to improved HE treatments.
  • Targeting ammonia detoxification and oxidative stress is crucial for managing HE.